NO20010114L - Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering - Google Patents
Profylaktiske behandlinger av neovaskularisering ved flekkdegenereringInfo
- Publication number
- NO20010114L NO20010114L NO20010114A NO20010114A NO20010114L NO 20010114 L NO20010114 L NO 20010114L NO 20010114 A NO20010114 A NO 20010114A NO 20010114 A NO20010114 A NO 20010114A NO 20010114 L NO20010114 L NO 20010114L
- Authority
- NO
- Norway
- Prior art keywords
- neovascularization
- prophylactic treatments
- spot degeneration
- degeneration
- spot
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP4607A AUPP460798A0 (en) | 1998-07-10 | 1998-07-10 | Method of treatment |
AUPP5847A AUPP584798A0 (en) | 1998-09-11 | 1998-09-11 | Method of treatment |
PCT/AU1999/000565 WO2000002564A1 (en) | 1998-07-10 | 1999-07-12 | Prophylactic treatments of neovascularisation in macular degeneration |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010114D0 NO20010114D0 (no) | 2001-01-08 |
NO20010114L true NO20010114L (no) | 2001-02-22 |
Family
ID=25645823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010114A NO20010114L (no) | 1998-07-10 | 2001-01-08 | Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050124594A1 (no) |
EP (1) | EP1104302A4 (no) |
JP (1) | JP2002520287A (no) |
KR (1) | KR20010071827A (no) |
CN (1) | CN1311684A (no) |
CA (1) | CA2336703A1 (no) |
NO (1) | NO20010114L (no) |
NZ (1) | NZ509797A (no) |
WO (1) | WO2000002564A1 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
EP1992317B1 (en) | 2000-08-30 | 2012-02-29 | Johns Hopkins University | Devices for intraocular drug delivery |
EP1550471A1 (en) * | 2000-11-29 | 2005-07-06 | Allergan Inc. | Intraocular implants for preventing transplant rejection in the eye |
AU3649502A (en) | 2000-11-29 | 2002-06-11 | Oculex Pharm Inc | Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
US20040091455A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
CA2504024A1 (en) * | 2002-10-31 | 2004-05-21 | Celgene Corporation | Composition for the treatment of macular degeneration |
US20050048099A1 (en) | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
CA2553381C (en) | 2004-01-20 | 2011-03-22 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
WO2005072744A1 (ja) * | 2004-02-02 | 2005-08-11 | Yuichi Kaji | 硝子体の可視化剤 |
EP1711186A4 (en) * | 2004-02-04 | 2009-03-18 | Retmed Pty Ltd | SLOWLY RELEASED STEROID COMPOSITION |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US20060089590A1 (en) | 2004-10-27 | 2006-04-27 | John Higuchi | Methods and devices for sustained in-vivo release of an active agent |
JP2008520242A (ja) * | 2004-11-18 | 2008-06-19 | イェール ユニバーシティ | 視覚障害を処置するための方法および組成物 |
JP5544458B2 (ja) | 2005-07-12 | 2014-07-09 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 疾病を治療するための医薬製品の製造においてトリロスタンiiiを使用する方法及びトリロスタンiiiを含む医薬製品 |
JP2009521510A (ja) * | 2005-12-23 | 2009-06-04 | アルコン,インコーポレイテッド | 眼への受容体チロシンキナーゼ阻害(rtki)化合物の送達のための医薬製剤 |
US8802128B2 (en) | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20080097335A1 (en) | 2006-08-04 | 2008-04-24 | Allergan, Inc. | Ocular implant delivery assemblies |
NL1033357C2 (nl) | 2007-02-08 | 2008-08-11 | Arnaldo Goncalves | Inrichting voor het met behulp van een injectie-naald intraoculair toedienen van een substantie, bijvoorbeeld een medicament, in een menselijk of dierlijk oog. |
MX2010009974A (es) | 2008-03-11 | 2010-09-30 | Alcon Res Ltd | Suspensiones de acetonida de triamcinolona de baja viscosidad, altamente floculadas para inyeccion intravitrea. |
SG2014008171A (en) | 2009-06-22 | 2014-04-28 | Ampio Pharmaceuticals Inc | Method for treatment of diseases |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
EP2855030B1 (en) | 2012-06-01 | 2019-08-21 | SurModics, Inc. | Apparatus and method for coating balloon catheters |
US9351979B2 (en) | 2012-12-19 | 2016-05-31 | Ampio Pharmaceuticals, Inc. | Methods of treatment of diseases |
CN104193987A (zh) * | 2013-01-21 | 2014-12-10 | 张雅珍 | 一种接枝药物的聚合物的制备和用途 |
AU2019207515A1 (en) | 2018-01-10 | 2020-07-30 | Eye Co Pty Ltd | Medical device and pharmaceutical composition for treatment of an eye disease or condition |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1972197A (en) * | 1932-04-20 | 1934-09-04 | William J Mccann | Hand protecting device |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4180646A (en) * | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
US4131648A (en) * | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
US5088498A (en) * | 1988-10-17 | 1992-02-18 | The Board Of Regents Of The University Of Washington | Ultrasonic plethysmograph |
US4946931A (en) * | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
US5310764A (en) * | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
AU7340694A (en) * | 1993-07-27 | 1995-02-28 | University Of Sydney, The | Treatment of age-related macular degeneration |
WO1995003807A1 (en) * | 1993-07-27 | 1995-02-09 | The University Of Sydney | Treatment of age-related macular degeneration |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968543A (en) * | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
DK0954305T3 (da) * | 1996-02-26 | 2003-08-25 | Advanced Res & Tech Inst | Anvendelse af carbonanhydraseinhibitorer til behandling af maculaødem |
AU717283B2 (en) * | 1996-10-30 | 2000-03-23 | Merck & Co., Inc. | Integrin antagonists |
DE19654750A1 (de) * | 1996-12-30 | 1998-07-02 | Helmut Dr Med Zander | Verwendung von Wirkstoffen mit Östrogen-Wirkung zur Vorbeugung und Behandlung von Makuladegeneration |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6596296B1 (en) * | 1999-08-06 | 2003-07-22 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
ES2231257T3 (es) * | 1999-10-21 | 2005-05-16 | Alcon Inc. | Dispositivo para la administracion de farmacos. |
US6395294B1 (en) * | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
CA2397194C (en) * | 2000-01-20 | 2011-05-17 | Mark E. Duggan | Alpha v integrin receptor antagonists |
US6866864B2 (en) * | 2000-03-20 | 2005-03-15 | Ahmed Mousa | Compositions and methods of use in the treatment of angiogenesis and vascular-related disorders |
US6613355B2 (en) * | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
US6696426B2 (en) * | 2000-08-22 | 2004-02-24 | Pharmacia Corporation | Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
-
1999
- 1999-07-12 JP JP2000558823A patent/JP2002520287A/ja active Pending
- 1999-07-12 EP EP99930939A patent/EP1104302A4/en not_active Withdrawn
- 1999-07-12 CA CA002336703A patent/CA2336703A1/en not_active Abandoned
- 1999-07-12 NZ NZ509797A patent/NZ509797A/en not_active IP Right Cessation
- 1999-07-12 CN CN99808257A patent/CN1311684A/zh active Pending
- 1999-07-12 WO PCT/AU1999/000565 patent/WO2000002564A1/en not_active Application Discontinuation
- 1999-07-12 KR KR1020017000395A patent/KR20010071827A/ko not_active Application Discontinuation
-
2001
- 2001-01-08 NO NO20010114A patent/NO20010114L/no not_active Application Discontinuation
-
2004
- 2004-10-15 US US10/966,627 patent/US20050124594A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050124594A1 (en) | 2005-06-09 |
EP1104302A1 (en) | 2001-06-06 |
EP1104302A4 (en) | 2006-08-09 |
CA2336703A1 (en) | 2000-01-20 |
WO2000002564A1 (en) | 2000-01-20 |
NZ509797A (en) | 2003-11-28 |
KR20010071827A (ko) | 2001-07-31 |
CN1311684A (zh) | 2001-09-05 |
JP2002520287A (ja) | 2002-07-09 |
NO20010114D0 (no) | 2001-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010114L (no) | Profylaktiske behandlinger av neovaskularisering ved flekkdegenerering | |
NO985652D0 (no) | Anvendelse av naaladaseinhibitorer ved behandling av kreft | |
NO984163L (no) | Forbedret syn ved fotodynamisk terapi av °yet | |
NO20003096L (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
NO973178D0 (no) | Indol-derivater anvendelige ved behandling av osteporose | |
NO990685L (no) | FremgangsmÕte ved inkubering av u°nsket smak i orale sammensetninger | |
NO992069D0 (no) | Konjugater som kan anvendes ved behandling av prostatakreft | |
DE69713907T2 (de) | Wasserenthärtende Zusammensetzungen und Waschmittelzusammensetzungen | |
DE19983141T1 (de) | Vernetzbare Zusammensetzung und daraus erhältlicher vernetzter Gegenstand | |
DE69727656D1 (de) | Kationischer elektrobeschichtungsprozess und beschichtungszusammensetzung dafür | |
AU2002211379A1 (en) | Compositions and methods for treatment of cystic fibrosis | |
EG22356A (en) | Pulveriser and method of pulverising | |
NO20023482D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
NO20003042L (no) | FremgangsmÕte for profylaktisk behandling av mastitt | |
DE69916503D1 (de) | Poliermittelzusammensetzung und anwendungsverfahren | |
AU2002231836A1 (en) | Method for treating and drying of wood | |
NO20001412D0 (no) | Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser | |
AU1359801A (en) | Methods and compositions for treating reward deficiency syndrome | |
AU5679899A (en) | Reduction of surfactant inactivation in pulmonary surfactant therapy | |
DE69939166D1 (de) | Wasserenthärtungs- und waschmittelzusammensetzungen | |
NO20002804D0 (no) | Konjugater som kan anvendes ved behandling av prostatakreft | |
NO20020031D0 (no) | Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi | |
NO995518D0 (no) | Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi | |
NO980786D0 (no) | Kombinasjonspreparat for anvendelse ved demens | |
ZA981781B (en) | The use of levobupivacaine in treating migraine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |